• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Summary of the American Heart Association's scientific statement on the relevance of genetics and genomics for prevention and treatment of cardiovascular disease.

作者信息

Arnett Donna K

出版信息

Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1682-6. doi: 10.1161/ATVBAHA.107.147207.

DOI:10.1161/ATVBAHA.107.147207
PMID:17634522
Abstract
摘要

相似文献

1
Summary of the American Heart Association's scientific statement on the relevance of genetics and genomics for prevention and treatment of cardiovascular disease.美国心脏协会关于遗传学和基因组学在心血管疾病预防与治疗中的相关性的科学声明摘要。
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1682-6. doi: 10.1161/ATVBAHA.107.147207.
2
Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group.遗传学和基因组学在心血管疾病预防与治疗中的相关性：美国心脏协会流行病学与预防委员会、中风委员会以及功能基因组学与转化生物学跨学科工作组的科学声明
Circulation. 2007 Jun 5;115(22):2878-901. doi: 10.1161/CIRCULATIONAHA.107.183679. Epub 2007 May 21.
3
Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.美国心脏协会关于女性心血管疾病预防的循证指南总结
Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):394-6. doi: 10.1161/01.ATV.0000121481.56512.c6.
4
Summary of the American Heart Association's scientific statement on drug therapy of high-risk lipid abnormalities in children and adolescents.美国心脏协会关于儿童和青少年高危脂质异常药物治疗的科学声明摘要。
Arterioscler Thromb Vasc Biol. 2007 May;27(5):982-5. doi: 10.1161/ATVBAHA.107.143644.
5
Summary of the American Heart Association scientific statement: promoting physical activity in children and youth: a leadership role for schools.美国心脏协会科学声明摘要：促进儿童和青少年的体育活动：学校的领导作用
J Cardiovasc Nurs. 2008 Jan-Feb;23(1):44-9. doi: 10.1097/01.JCN.0000305056.96247.bb.
6
Primary prevention of cardiovascular disease in nursing practice: focus on children and youth: a scientific statement from the American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in Youth of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity, and Metabolism.护理实践中心血管疾病的一级预防：关注儿童和青少年：美国心脏协会青少年心血管疾病理事会动脉粥样硬化、高血压和肥胖委员会、心血管护理理事会、流行病学与预防理事会以及营养、身体活动和代谢理事会的科学声明
Circulation. 2007 Jul 17;116(3):344-57. doi: 10.1161/CIRCULATIONAHA.107.184595. Epub 2007 Jun 25.
7
Genetic determinants of response to statins.他汀类药物反应的遗传决定因素。
Expert Rev Cardiovasc Ther. 2009 Aug;7(8):977-83. doi: 10.1586/erc.09.83.
8
Secondary prevention of coronary artery disease in elderly persons: a treatise on a report by the American Heart Association.
Am J Crit Care. 2006 Sep;15(5):514-8.
9
A New Guideline on Treatment of Hypertension in Those with Coronary Artery Disease: Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension About Treatment of Hypertension in Patients with Coronary Artery Disease.《冠状动脉疾病患者高血压治疗新指南：美国心脏协会、美国心脏病学会和美国高血压学会关于冠状动脉疾病患者高血压治疗的科学声明》
Heart Lung Circ. 2015 Nov;24(11):1037-40. doi: 10.1016/j.hlc.2015.05.022. Epub 2015 Jul 9.
10
Secondary stroke prevention.二级卒中预防
J Cardiovasc Nurs. 2008 Jan-Feb;23(1):34-41; quiz 42-3. doi: 10.1097/01.JCN.0000305059.81000.d3.

引用本文的文献

1
Use of the Corus® CAD Gene Expression Test for Assessment of Obstructive Coronary Artery Disease Likelihood in Symptomatic Non-Diabetic Patients.使用Corus® CAD基因表达检测评估有症状非糖尿病患者发生阻塞性冠状动脉疾病的可能性。
PLoS Curr. 2013 Aug 26;5:ecurrents.eogt.0f04f6081905998fa92b99593478aeab. doi: 10.1371/currents.eogt.0f04f6081905998fa92b99593478aeab.
2
The evolution and refinement of traditional risk factors for cardiovascular disease.传统心血管疾病风险因素的演变和完善。
Cardiol Rev. 2012 May-Jun;20(3):118-29. doi: 10.1097/CRD.0b013e318239b924.
3
Pharmacogenetics of heart failure: evidence, opportunities, and challenges for cardiovascular pharmacogenomics.
心力衰竭的药物遗传学：心血管药物基因组学的证据、机遇和挑战。
J Cardiovasc Transl Res. 2008 Mar;1(1):25-36. doi: 10.1007/s12265-007-9007-8. Epub 2008 Jan 29.